Medicare & Medicaid
News articles in this section include actions by federal regulators like the CMS and HHS, as well as information on Medicare and state Medicaid coverage and benefits.
Democrats are haggling over whether to drop two of the most popular elements of their social spending bill as negotiations reach the zero hour, according to a half-dozen sources close to the discussions. While high-level talks on the $1 trillion-plus package are ongoing, lawmakers, staffers, advocates and lobbyists said that a plan to expand Medicare ...
Medicare open enrollment kicked off Friday with more Medicare Advantage plans to choose from but with renewed criticism that insurers are gaming risk adjustment practices to inflate profits. While more and more insurers are expanding their presence in the MA marketplace, private Medicare plans are facing heightened scrutiny over risk adjustment and comprehensive diagnostic coding. ...
Large majorities of American voters across all political stripes favor letting Medicare negotiate drug prices, and most don't buy into the argument that high drug prices are needed for drug companies to invest in new research, according to a new poll from the Kaiser Family Foundation.
New data show that 7 in 10 Medicare beneficiaries didn’t compare plans during the 2018 open enrollment period, even though plans can change in their benefits and costs.
Nine out of 10 Medicare Advantage members are enrolled in plans that earned the government's highest quality marks for 2022, according to new federal data.
Donna Weiner looks at Medicare’s prescription drug program from two different points of view. As a participant, she wants to pay less for her medicines, which cost her about $6,000 a year. As a retired accountant who spent 50 years handling the books for companies, she sees a way to get there. “You know from working in ...
As Congress debates cutting prescription drug costs, a poll released Tuesday found the vast majority of adults — regardless of their political party or age — support letting the federal government negotiate drug prices for Medicare beneficiaries and those in private health insurance plans. The argument that pharmaceutical companies need to charge high prices to ...
Leadership may drop efforts to have the government directly negotiate the prices for medicines in private insurance plans and make fewer drugs subject to negotiations in Medicare, among the changes under consideration.
Democratic leaders struggling to satisfy both progressive and moderate factions’ demands are still trying to resolve divisions over scaling back the expansive health care policy wish list in their $3.5 trillion budget reconciliation package. A smattering of members in both chambers have concerns with key issues ranging from drug pricing to Medicare spending, while Democratic ...
There are many theories about what is (and what is not) a good indicator of a stock’s future growth (or decline). However, it is important to note that investment articles – for good reason – usually include an advisory about past performance not being a recommendation or guarantee of any future outcome or profit. Investing is a ...